Company Benitec Biopharma Limited Australian S.E.
Equities
BLT
AU000000BLT8
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jerel Banks
CEO | Chief Executive Officer | 49 | 30/09/16 |
Peter Roelvink
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/15 |
Megan Boston
CMP | Compliance Officer | 52 | 31/07/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
J. Buchi
BRD | Director/Board Member | 69 | 31/03/13 |
Edward Smith
BRD | Director/Board Member | 53 | 13/04/20 |
Peter Francis
BRD | Director/Board Member | 68 | 31/01/06 |
Jerel Banks
CEO | Chief Executive Officer | 49 | 30/09/16 |
Megan Boston
CMP | Compliance Officer | 52 | 31/07/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,341,586 | 8,165,062 ( 97.88 %) | 0 | 97.88 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |